AstraZeneca’s asthma drug Fasenra also works in a group of rare diseases that can lead to potentially fatal organ damage, a mid-stage trial has shown. Results of the phase 2 trial, published in the New England Journal of Medicine, demonstrated tha...
Original Article: AZ's Fasenra also works in rare organ damage diseases